StonvexLoading…
StonvexStonvexStonvexCore line items from RYZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.57B | $4.57B | $3.47B | $2.31B |
Operating Income | $23.20M | $-30.80M | $7.10M | $8.10M |
Net Income | $4.50M | $-56.40M | $-18.50M | $-3.70M |
EPS (Diluted) | $0.10 | $-1.76 | $-0.58 | $-0.12 |
Total Assets | $3.72B | $2.40B | $2.49B | $2.54B |
Total Liabilities | $2.43B | $1.64B | $1.69B | $1.72B |
Cash & Equivalents | $25.10M | $26.90M | $29.80M | $30.80M |
Free Cash Flow OCF − CapEx | $-191.40M | $35.50M | $-56.40M | $-35.30M |
Shares Outstanding | 43.16M | 32.12M | 32.09M | 32.03M |